Agents (siRNA, PNAs etc.)that reduce expression of the major UPR regulator Grp78/Bip, overexpressed by TrkAIII transfectants may target this mechanism to render TrkAIII-expressing tumour cells more sensitive to acute ER-stress-induced death. This evidence concerns the gene HSPA5 and neoplasm.